Epidermal Growth Factor Receptor

Known as: Transforming Growth Factor alpha Receptor, Receptor, TGF alpha, Receptor, ErbB-1 
A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF-related… (More)

Topic mentions per year

Topic mentions per year

1983-2017
0500100019832017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
With the evolution of technology, there is now a deeper understanding of glioblastoma as an inter- and intraheterogeneous disease… (More)
Is this relevant?
Review
2016
Review
2016
Patients with advanced melanoma have traditionally had very poor prognosis. However, since 2011 better understanding of the… (More)
Is this relevant?
Review
2015
Review
2015
Head and neck cancers, which affect 650,000 people and cause 350,000 deaths per year, is the sixth leading cancer by cancer… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Patients with non-small-cell lung cancer harbouring mutations in the epidermal growth factor receptor (EGFR) gene… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The mechanism by which the epidermal growth factor receptor (EGFR) is activated upon dimerization has eluded definition. We find… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene in lung cancers are… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The epidermal growth factor receptor (EGFR) signaling pathway is one of the most important pathways that regulate growth… (More)
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
CONTEXT More persons in the United States die from non-small cell lung cancer (NSCLC) than from breast, colorectal, and prostate… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The development and neoplastic progression of human astrocytic tumors appears to result through an accumulation of genetic… (More)
  • figure 2
  • figure 3
  • figure 5
Is this relevant?